Avant Swings to Profit as Recreational Cannabis Sales Jump 51%
AVTBF sits 48% above its 52-week low of $0.25.
Summary
Avant returned to positive net income of $0.2M in Q3 2026, versus a $1.9M loss a year earlier, and lifted Adjusted EBITDA to $1.3M from $0.2M. The swing came from mix, not volume: recreational revenue rose 51% to $4.1M and now exceeds half of net revenue, while export wholesale fell 50% to $2.1M and domestic wholesale dropped 52% to $1.1M, dragging total net revenue down 22% to $7.3M. Gross profit still improved to $2.5M from $1.7M on the higher-margin branded mix. The balance sheet is the real story for a company this size: interest-bearing debt is down to $0.9M from $8.1M in under two years, and the company generated $0.9M of operating cash flow in the quarter, though cash sits at just $1.1M. The Flowr LED retrofit is already showing up, with harvests up 57.5% sequentially to 1,272 kg, and an EU-GMP audit at that facility is complete but certification has not been granted.
At the time of this announcement, AVTBF was trading at $0.37 on OTC in the Life Sciences sector, with a market capitalization of approximately $5.7M. The 52-week trading range was $0.25 to $0.78. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.